Leuprorelin 1-month depot as neoadjuvant therapy for prostate cancer - Discussion

被引：0
|
作者：
Kulkarni
Prezioso
Parma
Yabwahr
Kesray
机构：
来源：
UROLOGIA INTERNATIONALIS | 1998年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：16 / 17
页数：2
相关论文
共 50 条
  • [21] Leuprorelin acetate depot (Eligard) in the treatment of prostate cancer: what do patients win?
    Matveev, V. B.
    Volkova, M. L.
    Kupchan, D. Z.
    Gridneva, Ya. V.
    ONKOUROLOGIYA, 2010, 6 (04): : 71 - +
  • [22] EVALUATION OF THE EFFICACY AND SAFETY OF SWITCHING FROM TREATMENT WITH LEUPROLIDE 1-MONTH DOSING REGIMEN TO DEGARELIX 1-MONTH DOSING REGIMEN IN PROSTATE CANCER (PCA) PATIENTS
    De La Rosette, J.
    Davis, I. I. I. R. L.
    Persson, B. E.
    Olesen, T. K.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 76 - 76
  • [23] Leuprolide Acetate 1-Month Depot for Central Precocious Puberty: Hormonal Suppression and Recovery
    Neely, E. Kirk
    Lee, Peter A.
    Bloch, Clifford A.
    Larsen, Lois
    Yang, Di
    Mattia-Goldberg, Cynthia
    Chwalisz, Kristof
    INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2010,
  • [24] Clinical study results of the new formulation leuprorelin acetate three-month depot for the treatment of advanced prostate carcinoma
    Fornara, P
    Jocham, D
    UROLOGIA INTERNATIONALIS, 1996, 56 : 18 - 22
  • [25] Preoperative neoadjuvant androgen withdrawal therapy in prostate cancer: The Canadian experience - Discussion
    Kantoff, PW
    Klotz, L
    D'Amico, AV
    Smith, MR
    Carroll, PR
    UROLOGY, 2002, 60 (3A) : 51 - 51
  • [26] Efficacy of Triptorelin 3-Month Depot Compared to 1-Month Depot for the Treatment of Korean Girls with Central Precocious Puberty in Single Tertiary Center
    Chung, Lindsey Yoojin
    Kang, Eungu
    Nam, Hyo-Kyoung
    Rhie, Young-Jun
    Lee, Kee-Hyoung
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2021, 36 (34) : 1 - 9
  • [27] Adjuvant and neoadjuvant therapy in prostate cancer
    Chay, C
    Smith, DC
    SEMINARS IN ONCOLOGY, 2001, 28 (01) : 3 - 12
  • [28] Neoadjuvant Exercise Therapy in Prostate Cancer
    Jones, Lee W.
    Moskowitz, Chaya S.
    Lee, Catherine P.
    Fickera, Gina A.
    Chun, Su S.
    Michalski, Meghan G.
    Stoeckel, Kurtis
    Underwood, Whitney P.
    Lavery, Jessica A.
    Bhanot, Umeshkumar
    Linkov, Irina
    Dang, Chau T.
    Ehdaie, Behfar
    Laudone, Vincent P.
    Eastham, James A.
    Collins, Anne
    Sheerin, Patricia T.
    Liu, Lydia Y.
    Eng, Stefan E.
    Boutros, Paul C.
    JAMA ONCOLOGY, 2024, 10 (09) : 1187 - 1194
  • [29] Real-world analysis of leuprorelin acetate microspheres-based neoadjuvant therapy for patients with high-risk prostate cancer
    Fu, Changde
    Xin, Jun
    Lai, Jinjin
    Zeng, Xu
    Wang, Yongnan
    Zhang, Wei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [30] Curability of prostate cancer in African Americans: Implications for neoadjuvant/adjuvant hormone therapy - Open discussion
    Roach, M
    Moul, JW
    MOLECULAR UROLOGY, 1998, 2 (03) : 213 - 213
12345